|
FDAAA Boosts Fees, Broadens Disclosure
|
|
|
| By
Jill Wechsler
|
|
|
|
Congress postpones debate on follow-on biologics while adopting new policies likely to reshape drug development
|
|
|
|
Venture Funding Returns to Life Sciences
|
|
|
| By
Brian O'Connell
|
|
|
|
The biopharmaceutical sector can look forward to a financially flush venture funding environment in 2008
|
|
|
|
The Difficulty of Giving Things Up
|
|
|
| By
Laura Bush
|
|
|
|
The challenge is not in coming up with a list of activities to discard, but in finding a feasible way to stop doing them.
|
|
|
|
Biotechnology and Life Sciences Education in China
|
|
|
| By
Eric S. Langer
,
Eliza Yibing Zhou
|
|
|
|
Biotechnology is definitely a hot topic in China—the country's administrators recently identified it as a "cornerstone of China's national economy by 2020." But most realize that getting there will require a better trained, specialized workforce than currently exists. The Chinese government has been pumping money into life sciences education as part of its plan to achieve a global biotechnological presence over the next 15 years.
|
|
|
|
How to Develop a Pool of Talented People
|
|
|
| By
John W. Dobiecki
|
|
|
|
CMOs must take a proactive approach to ensure the availability of local talent
|
|
|
|
How to Make Improvement Programs Work
|
|
|
| By
Marc Puich
|
|
|
|
A true visionary leadership is required to drive the progress of operational excellence programs in biopharmaceutical organizations
|
|
|
